Editorial: Neuroplasticity in multiple sclerosis

Editorial: Neuroplasticity in multiple sclerosis

Saved in:

Bibliographic Details
Main Authors:	Yavor Yalachkov, Soheila Karimi-Abdolrezaee, Eleonora Tavazzi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Neurology
Subjects:	multiple sclerosis neuroplasticity neuroprotection neuroregeneration remyelination BDNF
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1550152/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Towards Treating Multiple Sclerosis Progression
by: Darius Häusler, et al.
Published: (2024-11-01)

Exercise-Induced Neuroplasticity: Adaptive Mechanisms and Preventive Potential in Neurodegenerative Disorders
by: Masab Mansoor, et al.
Published: (2025-04-01)

Neuroplasticity in Multiple Sclerosis: Implications for Rehabilitation
by: Srishti Bipul Banerjee
Published: (2024-10-01)

Hypoxic Neuroinflammation in the Pathogenesis of Multiple Sclerosis
by: Bethany Y. A. Hollingworth, et al.
Published: (2025-02-01)

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis
by: David Qixiang Chen, et al.
Published: (2025-02-01)

INVESTIGATING A TECHNOLOGY TO RESTORE SIGNAL TRANSMISSION ACROSS DEMYELINATED AXONS IN MULTIPLE SCLEROSIS: A COMPREHENSIVE REVIEW
by: Chathurika AGJ, et al.
Published: (2025-04-01)

The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis
by: Femke Van Gaever, et al.
Published: (2024-12-01)

Neuroplasticity in Depressive Disorders: The Role of BDNF in Linking Pharmacotherapy and Physical Activity
by: Maciej Mamczur, et al.
Published: (2024-12-01)

Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro
by: Larissa Jank, et al.
Published: (2024-07-01)

Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
by: Dennis Bourdette, et al.
Published: (2024-07-01)

Inhibition of phosphodiesterase‐4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination
by: Yasir A. Syed, et al.
Published: (2013-10-01)

Determinants driving the evolution of new multiple sclerosis lesions into chronic active or remyelinated states
by: G. Boffa, et al.
Published: (2025-01-01)

Siponimod supports remyelination in the non-supportive environment
by: Johann Krüger, et al.
Published: (2025-02-01)

Repair mechanisms of the central nervous system: From axon sprouting to remyelination
by: Lauren Gluck, et al.
Published: (2025-07-01)

Clinical and paraclinical features distinguish fatigue from depression-predominant phenotypes in multiple sclerosis
by: Yavor Yalachkov, et al.
Published: (2025-05-01)

Possibilities of pharmacologic correction of cognitive disorders in conditions of experimental equivalent of multiple sclerosis
by: Nefyodov A.A., et al.
Published: (2015-06-01)

Possibilities of pharmacologic correction of cognitive disorders in conditions of experimental equivalent of multiple sclerosis.
by: A. A. Nefyodov, et al.
Published: (2015-06-01)

Multiple sclerosis in 2020
by: Anshu Rohatgi, et al.
Published: (2021-01-01)

BDNF gene polymorphisms and BDNF serum concentration in schizophrenia patients: a pilot study
by: Anastasiia S. Boiko, et al.
Published: (2025-05-01)

Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis
by: Mustafa Sindi, et al.
Published: (2025-03-01)

THE PHENOMENON OF NEUROPLASTICITY IN THE MECHANISMS OF REFLEXOTHERAPY
by: G. M. Karimova, et al.
Published: (2019-05-01)

BRAIN-COMPUTER INTERFACES IN NEUROREHABILITATION FOR CENTRAL NERVOUS SYSTEM DISEASES: APPLICATIONS IN STROKE, MULTIPLE SCLEROSIS AND PARKINSON’S DISEASE
by: Knezevic Sara
Published: (2025-05-01)

Terapeutic hypothermia in neuroprotection has an impact on neuroplasticity in brain ischemia and trauma
by: F.V. Hladkykh, et al.
Published: (2025-02-01)

MXene-Reinforced Composite Cryogel Scaffold for Neural Tissue Repair
by: Mohamed Zoughaib, et al.
Published: (2025-01-01)

BDNF Signaling and Pain Modulation
by: Mariacristina Mazzitelli, et al.
Published: (2025-03-01)

Genetically modified macrophages accelerate myelin repair
by: Marie‐Stéphane Aigrot, et al.
Published: (2022-07-01)

Evaluation of transcriptomic changes after photobiomodulation in spinal cord injury
by: Andrew R. Stevens, et al.
Published: (2025-01-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01)

Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression
by: Enrico Ginelli, et al.
Published: (2025-04-01)

The dynamic relationship of brain‐derived neurotrophic factor and oxytocin: Introducing the concept of neurosocial plasticity
by: Jamshid Faraji, et al.
Published: (2025-03-01)

Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple sclerosis
by: Igal Rosenstein, et al.
Published: (2024-12-01)

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)

Optimization of therapy in secondary progressive multiple sclerosis
by: A. N. Boyko, et al.
Published: (2024-08-01)

Transcranial Magnetic stimulation in Neurodegenerative Diseases: Basics and Clinical Applications
by: Burak Yuluğ, et al.
Published: (2021-12-01)

Editorial: Neuroplasticity and imaging methods in rehabilitation
by: Ilan Laufer, et al.
Published: (2024-12-01)

Oligodendroglial heterogeneity in health, disease, and recovery: deeper insights into myelin dynamics
by: Pieter-Jan Serneels, et al.
Published: (2025-11-01)

Paramyxoviruses and Multiple Sclerosis
by: Baghdad Science Journal
Published: (2012-09-01)

Olfactory alterations in patients with multiple sclerosis
by: Sergio Semeraro Jordy, et al.

The regulation of microglia by aging and autophagy in multiple sclerosis
by: Xiying Wang, et al.
Published: (2025-06-01)

Combined Use of Intranasal Methylprednisolone and Allopregnanolone: Revisiting Anti-inflammatory and Remyelinating Treatment in a Murine Model of Multiple Sclerosis
by: Iván Nicolás Pérez-Osorio, et al.
Published: (2024-12-01)